Resultados
Investigadores de IBIMA Plataforma BIONAND demuestran los efectos del dimetil fumarato en el metabolismo energético
Investigadores de IBIMA Plataforma BIONAND, pertenecientes al grupo ‘SIBIUMA, Bases Moleculares de los Sistemas...
Estrategia de Recursos Humanos
Estrategia de Recursos HumanosEl Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina, IBIMA...
Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial
Merchante, N; Carcel, S; Garrido-Gracia, JC; Trigo-Rodriguez, M; Moreno, MAE; Leon-Lopez, R; Espindola-Gomez, R; Alonso, EA; Garcia, DV; Romero-Palacios, A; Perez-Camacho, I; Gutierrez-Gutierrez, B; Martinez-Marcos, FJ; Fernandez-Roldan, C; Perez-Crespo, PMM; Cano, AA; Leon, E; Corzo, JE; de la Fuente, C; Torre-Cisneros, J – 2022
2-(Fluoromethoxy)-4 ‘-(S-methanesulfonimidoyl)-1,1 ‘-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D-1 Receptor for Parkinson’s Disease.
Garcia-Carceles, J; Vazquez-Villa, H; Brea, J; De Guevara-Miranda, DL; Cincilla, G; Sanchez-Martinez, M; Sanchez-Merino, A; Algar, S; De los Frailes, MT; Roberts, RS; Ballesteros, JA; De Fonseca, FR; Benhamu, B; Loza, MI; Lopez-Rodriguez, ML – 2022
2-(Fluoromethoxy)-4 ‘-(S-methanesulfonimidoyl)-1,1 ‘-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D-1 Receptor for Parkinson’s Disease
Garcia-Carceles, J; Vazquez-Villa, H; Brea, J; De Guevara-Miranda, DL; Cincilla, G; Sanchez-Martinez, M; Sanchez-Merino, A; Algar, S; De los Frailes, MT; Roberts, RS; Ballesteros, JA; De Fonseca, FR; Benhamu, B; Loza, MI; Lopez-Rodriguez, ML – 2022
Are Measures of Physical Function of the Neck Region Associated With Poor Prognosis Following a Whiplash Trauma? A Systematic Review
Alalawi, A; Mazaheri, M; Gallina, A; Luque-Suarez, A; Sterling, M; Falla, D – 2022
Effect of Moderate Consumption of Different Phenolic-Content Beers on the Human Gut Microbiota Composition: A Randomized Crossover Trial
Martinez-Montoro, JI; Quesada-Molina, M; Gutierrez-Repiso, C; Ruiz-Limon, P; Subiri-Verdugo, A; Tinahones, FJ; Moreno-Indias, I – 2022
Lipid profile of patients treated with evolocumab in Spanish hospital nephrology units (RETOSS NEFRO)
Goicoechea, M; Alvarez, V; Segarra, A; Polaina, M; Martin-Reyes, G; Robles, NR; Escudero, V; Orellana, C; Granell, SB; de Juan-Ribera, J; Lucas, MF; Grana, JM; Reque, J; Hernandez, RS; Villamayor, S; Gorriz, JL – 2022